Eyenuk, Inc.

Eyenuk, Inc., is a global artificial intelligence (AI) medical technology company and the leader in real-worldAI Eye Screening™for autonomous disease detection andAI Predictive Biomarkers™for risk assessment and disease surveillance.

Harnessing the power of AI to analyze retinal images was the inspiration of Eyenuk Founder & CEO Kaushal Solanki. During his own health scare, Solanki faced a four-month long wait to see a specialist about his retinal scans. His own father’s struggle with diabetes led Solanki to better understand the risks of diabetic retinopathy, as well as the shortage of qualified professionals to address the issue.

Our Mission

Eyenuk is accelerating the world’s transition to predictive and preventative healthcare with innovative, AI-driven diagnostic solutions.

Eyenuk is on a mission toscreen every eye in the worldto ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease.